Remote ABA Therapy Webinar

ABA Telehealth Webinar: How to Support Families Remotely

Recorded on: Thursday, March 19th, 2020

Helpful Resources:

In response to the current COVID-19 pandemic, Rethink will be holding a special webinar to help ABA providers support the clients and families they serve through this time of uncertainty.

This webinar will be an overview of ABA telehealth strategies to support families remotely.  We will include best practices from seasoned clinicians in our employee benefits division, who coach and train parents remotely.  An overview of billing codes for telehealth services will also be provided by our business solutions team.

Expect to discuss:

Real-life lessons of a BCBA who has done remote consultation/telehealth with parents

  • Best practices for engaging parents as partners in the treatment process
  • Some tips to remember when starting this type of work will be provided
  • Utilizing video conferencing to work with families

Clinical utilization of the Rethink parent portal, specifically:

  • How to grant parents/guardians access to their child’s Rethink account
  • Resources and Trainings for parents
  • Updating programming and behavior plans to focus on parent training and data collection

Practice Management utilization of Rethink, including how to:

  • Update your Rethink system to account for telehealth modifiers
  • Schedule telehealth
  • Update session note templates for telehealth
  • Where telehealth will be indicated on the billing export

This webinar is free and does not offer CEUs.


Picture of Erin and Diana

Translating Medical Necessity Criteria for ABA Providers

Long-standing research on the effects of ABA services to treat ASD indicates that treatment intensity may greatly influence the response to treatment in children.

As such, clinicians should carefully calibrate and adhere to dosage recommendations.

Studies have concluded that adhering to prescribed treatment dosages, aligned with published research, improves outcome mastery and increases adaptive behavior skills.

Legislative advocacy and policy development efforts in the elimination of managed health plans perceived prescriptive authority over medical necessity determination have been a priority of many clinicians, lawyers and policymakers.

However, understanding the health plan’s role in medical necessity and utilization management, as well as limitations in the ability to conduct well-controlled research on the intensity of treatment recommendation remains a challenge.

Despite best practice standards and available research supporting proper dosage recommendations, the variability in dosage recommendations may still be negatively influenced by a variety of factors.

These include, but are not limited to:

  • A complex language barrier between the clinician and the health plan
  • Lack of clinician training in what is medically necessary
  • Unlawful or otherwise ineffective mandates enforced by funding sources
  • Limitations in applied research 

Prescription fidelity affects both the clinical and operational sides of the effective delivery of autism services.

As the field of Autism Services has continued to grow, the appropriate measures of clinical quality remain embedded in providing the adequate intensity of service on the individual patient level.

The drastic under-prescribing of care, that is industry-wide, affects the ability for patients to receive optimum results.

It also creates additional administrative costs and burdens on autism providers, which results in scaling and fiscal management challenges.

To continue the conversations related to the medical necessity of autism treatment, the development of a medical necessity review tool may lend guidance for clinicians.

This will help them move toward consistency in considerations of medical necessity justification and appropriate dosage.

To register for this event: Click Here